Speaking at TCT 2023 (23–26 October, San Francisco), vascular surgeon Ramon Varcoe (Sydney, Australia) reflects on the wider impact of the results of the LIFE-BTK trial on chronic limb-threatening ischaemia (CLTI) treatment.
Speaking at TCT 2023 (23–26 October, San Francisco), vascular surgeon Ramon Varcoe (Sydney, Australia) reflects on the wider impact of the results of the LIFE-BTK trial on chronic limb-threatening ischaemia (CLTI) treatment.